[{"quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed130", "question_id": "20251223T232137723Z_gemini-3-pro-preview_seed130-001", "question": "A 52-year-old male presents with severe chronic watery diarrhea and 15 kg weight loss over 6 months. He has a history of hypertension treated with olmesartan and amlodipine. Celiac serologies (tTG-IgA, EMA) are negative. Upper endoscopy reveals scalloping of duodenal folds; biopsy shows total villous atrophy and increased intraepithelial lymphocytes. HLA-DQ2 and HLA-DQ8 genotyping is negative. A gluten-free diet for 8 weeks yields no clinical improvement. What is the most likely diagnosis?", "options": ["Refractory Celiac Disease Type 1", "Autoimmune Enteropathy", "Olmesartan-associated Enteropathy", "Common Variable Immunodeficiency (CVID)", "Tropical Sprue"], "answer": "C", "answer_index": 2, "explanation": "Olmesartan-associated enteropathy mimics celiac disease histologically (villous atrophy) but occurs in patients without the genetic predisposition for celiac disease (HLA-DQ2/DQ8 negative). The key discriminator is the medication history and lack of response to gluten withdrawal. Refractory celiac disease requires a prior confirmed diagnosis of celiac disease (positive genetics/serology).", "generator_model": "gemini-3-pro-preview", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Gastrointestinal", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The vignette presents a classic case of olmesartan-associated enteropathy. The patient exhibits severe diarrhea, weight loss, and histologic findings of villous atrophy (sprue-like enteropathy) while taking olmesartan. The critical discriminating factors are the negative celiac serologies, the lack of response to a gluten-free diet, and most importantly, the negative HLA-DQ2/DQ8 genotyping. In the context of medical board exams, negative HLA-DQ2/DQ8 effectively rules out celiac disease (high negative predictive value). Therefore, Refractory Celiac Disease (Option A) is incorrect because the patient does not have the prerequisite diagnosis of celiac disease. While Common Variable Immunodeficiency (Option D) and Autoimmune Enteropathy (Option B) can cause similar histologic findings, the specific history of olmesartan use combined with the exclusion of celiac disease makes Option C the unique best answer. The item is medically accurate, logically sound, and relies on well-established associations.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The vignette presents a classic case of olmesartan-associated enteropathy. The patient exhibits severe diarrhea, weight loss, and histologic findings of villous atrophy (sprue-like enteropathy) while taking olmesartan. The critical discriminating factors are the negative celiac serologies, the lack of response to a gluten-free diet, and most importantly, the negative HLA-DQ2/DQ8 genotyping. In the context of medical board exams, negative HLA-DQ2/DQ8 effectively rules out celiac disease (high negative predictive value). Therefore, Refractory Celiac Disease (Option A) is incorrect because the patient does not have the prerequisite diagnosis of celiac disease. While Common Variable Immunodeficiency (Option D) and Autoimmune Enteropathy (Option B) can cause similar histologic findings, the specific history of olmesartan use combined with the exclusion of celiac disease makes Option C the unique best answer. The item is medically accurate, logically sound, and relies on well-established associations.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed130", "question_id": "20251223T232137723Z_gemini-3-pro-preview_seed130-002", "question": "A 34-year-old female with a history of oral contraceptive use presents with right upper quadrant pain. MRI of the liver reveals a 6 cm solitary lesion in segment V. The lesion is hyperintense on T2-weighted images, shows strong arterial enhancement, and retains contrast on the hepatobiliary phase of Eovist (gadoxetate) MRI. Biopsy shows hepatocytes with glutamine synthetase diffuse strong positivity. What is the most appropriate management?", "options": ["Discontinue oral contraceptives and surveillance imaging in 6 months", "Surgical resection", "Radiofrequency ablation", "Liver transplantation evaluation", "Reassurance and discharge"], "answer": "B", "answer_index": 1, "explanation": "The imaging and staining pattern (diffuse glutamine synthetase positivity) are diagnostic of a beta-catenin activated hepatocellular adenoma. Unlike HNF1A-inactivated or inflammatory adenomas, beta-catenin activated adenomas have a very high risk of malignant transformation to hepatocellular carcinoma (HCC) and do not regress significantly with OCP cessation. Resection is mandated regardless of size or symptoms.", "generator_model": "gemini-3-pro-preview", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Gastrointestinal", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The item is medically accurate and logically sound. The clinical vignette describes a patient with a 6 cm liver lesion. The key diagnostic features are the MRI finding of hepatobiliary phase contrast retention (suggesting FNH or beta-catenin activated adenoma) and the biopsy showing 'diffuse strong' glutamine synthetase (GS) positivity. While FNH shows 'map-like' GS staining, diffuse strong positivity is pathognomonic for beta-catenin activated hepatocellular adenoma. This subtype carries a significant risk of malignant transformation to hepatocellular carcinoma. Furthermore, the lesion is >5 cm and symptomatic. Current guidelines (EASL, ACG) recommend surgical resection for all beta-catenin activated adenomas (regardless of size) and generally for any adenoma >5 cm due to hemorrhage/malignancy risk. Therefore, Option B (Surgical resection) is the unique best answer. Option A is incorrect because cessation of OCPs is insufficient for this high-risk subtype and size. Option E is incorrect because the GS pattern rules out FNH.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The item is medically accurate and logically sound. The clinical vignette describes a patient with a 6 cm liver lesion. The key diagnostic features are the MRI finding of hepatobiliary phase contrast retention (suggesting FNH or beta-catenin activated adenoma) and the biopsy showing 'diffuse strong' glutamine synthetase (GS) positivity. While FNH shows 'map-like' GS staining, diffuse strong positivity is pathognomonic for beta-catenin activated hepatocellular adenoma. This subtype carries a significant risk of malignant transformation to hepatocellular carcinoma. Furthermore, the lesion is >5 cm and symptomatic. Current guidelines (EASL, ACG) recommend surgical resection for all beta-catenin activated adenomas (regardless of size) and generally for any adenoma >5 cm due to hemorrhage/malignancy risk. Therefore, Option B (Surgical resection) is the unique best answer. Option A is incorrect because cessation of OCPs is insufficient for this high-risk subtype and size. Option E is incorrect because the GS pattern rules out FNH.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed130", "question_id": "20251223T232137723Z_gemini-3-pro-preview_seed130-003", "question": "A 24-year-old female presents with menorrhagia and prolonged bleeding after a tooth extraction. Coagulation profile shows a prolonged aPTT (55s) and normal PT. Factor VIII activity is 6% (low). von Willebrand Factor (vWF) Antigen is 95% (normal), and vWF Ristocetin Cofactor Activity is 92% (normal). A mixing study corrects the aPTT. Her father has a similar bleeding history, but her brothers are unaffected. What is the most likely diagnosis?", "options": ["Hemophilia A (Carrier state)", "Type 2N von Willebrand Disease", "Type 2A von Willebrand Disease", "Acquired Hemophilia A", "Factor XI Deficiency"], "answer": "B", "answer_index": 1, "explanation": "Type 2N (Normandy) vWD is caused by a defect in the vWF binding domain for Factor VIII, leading to a secondary deficiency of Factor VIII (due to short half-life) despite normal vWF levels and function. It mimics Hemophilia A but exhibits autosomal recessive inheritance (affecting females significantly), whereas Hemophilia A is X-linked. The normal vWF antigen and activity rule out Type 1 and 2A/2B/2M.", "generator_model": "gemini-3-pro-preview", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Hematology", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The question presents a classic board-exam scenario for Type 2N von Willebrand Disease (vWD). The patient is a female with a 'Hemophilia A' phenotype (low Factor VIII, prolonged aPTT, normal PT) but has normal vWF antigen and Ristocetin cofactor activity. This specific profile—low FVIII with normal vWF quantity and platelet-binding function—is the hallmark of Type 2N (Normandy), where the defect lies in the vWF domain that binds Factor VIII. While a Hemophilia A carrier (Option A) could theoretically have low FVIII due to extreme lyonization, a level of 6% is exceptionally low for a carrier (typically 30–50%) and strongly points to Type 2N in a female patient. Acquired Hemophilia (Option D) is ruled out because the mixing study corrects. Type 2A (Option C) is ruled out by the normal Ristocetin cofactor activity. Factor XI deficiency (Option E) is excluded by the specific finding of low Factor VIII. The item is logically sound, medically accurate, and tests a well-defined discriminating concept in hematology.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The question presents a classic board-exam scenario for Type 2N von Willebrand Disease (vWD). The patient is a female with a 'Hemophilia A' phenotype (low Factor VIII, prolonged aPTT, normal PT) but has normal vWF antigen and Ristocetin cofactor activity. This specific profile—low FVIII with normal vWF quantity and platelet-binding function—is the hallmark of Type 2N (Normandy), where the defect lies in the vWF domain that binds Factor VIII. While a Hemophilia A carrier (Option A) could theoretically have low FVIII due to extreme lyonization, a level of 6% is exceptionally low for a carrier (typically 30–50%) and strongly points to Type 2N in a female patient. Acquired Hemophilia (Option D) is ruled out because the mixing study corrects. Type 2A (Option C) is ruled out by the normal Ristocetin cofactor activity. Factor XI deficiency (Option E) is excluded by the specific finding of low Factor VIII. The item is logically sound, medically accurate, and tests a well-defined discriminating concept in hematology.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed130", "question_id": "20251223T232137723Z_gemini-3-pro-preview_seed130-004", "question": "A 19-year-old male presents with recurrent fevers, livedo reticularis, and two episodes of lacunar ischemic stroke. Laboratory evaluation reveals low serum IgM and IgG levels, mild neutropenia, and elevated inflammatory markers. A biopsy of a skin nodule shows necrotizing vasculitis. Genetic testing is most likely to reveal a loss-of-function mutation in which gene?", "options": ["MEFV", "ADA2", "NOD2", "TNFRSF1A", "STAT3"], "answer": "B", "answer_index": 1, "explanation": "This clinical presentation is classic for Deficiency of Adenosine Deaminase 2 (DADA2). It presents with a polyarteritis nodosa (PAN)-like vasculitis, early-onset strokes, and mild immunodeficiency (hypogammaglobulinemia/cytopenias). It is an autosomal recessive autoinflammatory disease. MEFV causes Familial Mediterranean Fever; STAT3 causes Hyper-IgE syndrome.", "generator_model": "gemini-3-pro-preview", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Immunology", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The vignette describes a classic presentation of Deficiency of Adenosine Deaminase 2 (DADA2). Key discriminating features include the combination of systemic inflammation (fevers, elevated markers), vasculopathy (livedo reticularis, necrotizing vasculitis, and specifically early-onset lacunar strokes), and mild immunodeficiency (hypogammaglobulinemia, neutropenia). DADA2 is an autosomal recessive condition caused by loss-of-function mutations in the ADA2 gene (formerly CECR1). The keyed answer (B) is the correct etiology. The distractors are distinct autoinflammatory or immunodeficiency genes: MEFV (Familial Mediterranean Fever), NOD2 (Blau syndrome/Crohn's), TNFRSF1A (TRAPS), and STAT3 (Hyper-IgE syndrome or autoimmune enteropathy). None of the distractors account for the specific triad of stroke, vasculitis, and humoral immunodeficiency. The item is medically accurate, logically sound, and points to a unique best answer.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The vignette describes a classic presentation of Deficiency of Adenosine Deaminase 2 (DADA2). Key discriminating features include the combination of systemic inflammation (fevers, elevated markers), vasculopathy (livedo reticularis, necrotizing vasculitis, and specifically early-onset lacunar strokes), and mild immunodeficiency (hypogammaglobulinemia, neutropenia). DADA2 is an autosomal recessive condition caused by loss-of-function mutations in the ADA2 gene (formerly CECR1). The keyed answer (B) is the correct etiology. The distractors are distinct autoinflammatory or immunodeficiency genes: MEFV (Familial Mediterranean Fever), NOD2 (Blau syndrome/Crohn's), TNFRSF1A (TRAPS), and STAT3 (Hyper-IgE syndrome or autoimmune enteropathy). None of the distractors account for the specific triad of stroke, vasculitis, and humoral immunodeficiency. The item is medically accurate, logically sound, and points to a unique best answer.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed130", "question_id": "20251223T232137723Z_gemini-3-pro-preview_seed130-005", "question": "A 65-year-old male with metastatic colorectal cancer is being evaluated for third-line therapy. Molecular profiling reveals the tumor is KRAS wild-type, NRAS wild-type, and BRAF V600E mutated. Microsatellite status is stable (MSS). Which of the following regimens is the most appropriate targeted therapy?", "options": ["Vemurafenib monotherapy", "Encorafenib plus Cetuximab", "Dabrafenib plus Trametinib", "Pembrolizumab monotherapy", "Regorafenib monotherapy"], "answer": "B", "answer_index": 1, "explanation": "In BRAF V600E-mutated colorectal cancer, BRAF inhibitor monotherapy (e.g., Vemurafenib) is ineffective due to a feedback loop that causes rapid upregulation of EGFR signaling. The standard of care, based on the BEACON trial, is the combination of a BRAF inhibitor (Encorafenib) and an EGFR inhibitor (Cetuximab) to block this feedback loop. Pembrolizumab is only for MSI-High tumors.", "generator_model": "gemini-3-pro-preview", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Medical Oncology", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V. Verdict on keyed answer: Correct best. The question accurately tests the standard of care for previously treated metastatic colorectal cancer with a BRAF V600E mutation. Based on the pivotal BEACON CRC trial, the combination of Encorafenib and Cetuximab (Option B) is the FDA-approved and NCCN Category 1 preferred regimen for this indication. BRAF inhibitor monotherapy (Option A) is known to be ineffective in CRC due to EGFR-mediated feedback signaling. Pembrolizumab (Option D) is incorrect because the patient is Microsatellite Stable (MSS), whereas immunotherapy is indicated for MSI-High tumors. Dabrafenib plus Trametinib (Option C) is the standard for BRAF-mutated melanoma and NSCLC, not CRC. Regorafenib (Option E) is a general third-line option, but for a patient with a specific actionable driver like BRAF V600E, the targeted combination is clinically superior and the correct answer. The item is logically sound and medically precise.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. The question accurately tests the standard of care for previously treated metastatic colorectal cancer with a BRAF V600E mutation. Based on the pivotal BEACON CRC trial, the combination of Encorafenib and Cetuximab (Option B) is the FDA-approved and NCCN Category 1 preferred regimen for this indication. BRAF inhibitor monotherapy (Option A) is known to be ineffective in CRC due to EGFR-mediated feedback signaling. Pembrolizumab (Option D) is incorrect because the patient is Microsatellite Stable (MSS), whereas immunotherapy is indicated for MSI-High tumors. Dabrafenib plus Trametinib (Option C) is the standard for BRAF-mutated melanoma and NSCLC, not CRC. Regorafenib (Option E) is a general third-line option, but for a patient with a specific actionable driver like BRAF V600E, the targeted combination is clinically superior and the correct answer. The item is logically sound and medically precise.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed130", "question_id": "20251223T232137723Z_gemini-3-pro-preview_seed130-006", "question": "A 45-year-old male presents with recurrent episodes of hypotension and syncope occurring 3 to 6 hours after eating dinner. He has no history of atopy. Skin prick tests to beef, pork, and lamb are negative, but intradermal testing is positive. Serum tryptase is normal. Specific IgE testing reveals elevated IgE to galactose-alpha-1,3-galactose. Which of the following is the most likely vector for sensitization in this patient?", "options": ["Ixodes scapularis (Black-legged tick)", "Amblyomma americanum (Lone Star tick)", "Dermacentor variabilis (American Dog tick)", "Aedes aegypti (Mosquito)", "Ctenocephalides felis (Cat flea)"], "answer": "B", "answer_index": 1, "explanation": "This is Alpha-gal syndrome, a delayed anaphylactic reaction to mammalian meat (red meat) mediated by IgE against the alpha-gal carbohydrate. Sensitization is caused by bites from the Lone Star tick (*Amblyomma americanum*) in the US. The reaction is characteristically delayed (3-6 hours) unlike typical protein-based food allergies.", "generator_model": "gemini-3-pro-preview", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Allergy/Immunology", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\n\\nThe vignette describes a classic presentation of Alpha-gal syndrome: delayed anaphylaxis (3–6 hours) after ingesting mammalian meat, negative skin prick tests (often false negative due to low sensitivity for this specific antigen), positive intradermal tests, and specific IgE to galactose-alpha-1,3-galactose. The question asks for the vector of sensitization. In North America, the Lone Star tick (*Amblyomma americanum*) is the established vector responsible for inducing this specific IgE response. While *Ixodes* species cause similar sensitization in Europe and Australia, *Ixodes scapularis* (Option A) is the vector for Lyme disease in the US, not Alpha-gal. The other options are vectors for unrelated diseases (RMSF, arboviruses, etc.). Therefore, Option B is the unique best answer. The item is medically accurate and logically sound.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\n\nThe vignette describes a classic presentation of Alpha-gal syndrome: delayed anaphylaxis (3–6 hours) after ingesting mammalian meat, negative skin prick tests (often false negative due to low sensitivity for this specific antigen), positive intradermal tests, and specific IgE to galactose-alpha-1,3-galactose. The question asks for the vector of sensitization. In North America, the Lone Star tick (*Amblyomma americanum*) is the established vector responsible for inducing this specific IgE response. While *Ixodes* species cause similar sensitization in Europe and Australia, *Ixodes scapularis* (Option A) is the vector for Lyme disease in the US, not Alpha-gal. The other options are vectors for unrelated diseases (RMSF, arboviruses, etc.). Therefore, Option B is the unique best answer. The item is medically accurate and logically sound.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed130", "question_id": "20251223T232137723Z_gemini-3-pro-preview_seed130-007", "question": "A 78-year-old female is evaluated for progressive visual dysfunction. She reports difficulty reading and navigating her home, often bumping into doorframes. Her family notes she cannot reach for objects accurately (optic ataxia) and cannot describe the entire scene of a picture (simultanagnosia). Memory and language are relatively preserved. MRI shows predominant atrophy of the parietal and occipital lobes. What is the most likely underlying pathology?", "options": ["Lewy Body Disease", "Prion Disease (CJD)", "Alzheimer's Disease pathology (Amyloid plaques/Tau tangles)", "Frontotemporal Lobar Degeneration (TDP-43)", "Vascular Dementia"], "answer": "C", "answer_index": 2, "explanation": "This patient presents with Posterior Cortical Atrophy (PCA), also known as Benson's syndrome. The clinical hallmark is Balint's syndrome (simultanagnosia, optic ataxia, oculomotor apraxia) and Gerstmann's syndrome. Despite the atypical visual presentation, the underlying pathology in the vast majority (>80%) of PCA cases is Alzheimer's disease (amyloid plaques and neurofibrillary tangles).", "generator_model": "gemini-3-pro-preview", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Geriatrics", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V. Verdict on keyed answer: Correct best. The vignette describes a classic presentation of Posterior Cortical Atrophy (PCA), also known as Benson's syndrome. Key features include progressive higher-order visual dysfunction (Balint's syndrome: optic ataxia, simultanagnosia) and specific parietal/occipital atrophy, with relative preservation of memory and language. The question asks for the most likely underlying pathology. Medical consensus establishes that Alzheimer's Disease pathology (amyloid plaques and neurofibrillary tangles) is the underlying cause in the vast majority (>80%) of PCA cases. While the Heidenhain variant of CJD (Option B) affects vision, it typically presents with rapid progression and cortical ribboning on DWI, not just atrophy. Lewy Body Disease (Option A) can have visual features but is less likely to present as pure PCA without hallucinations or parkinsonism, and AD remains the statistical favorite. The item is medically accurate and logically sound.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. The vignette describes a classic presentation of Posterior Cortical Atrophy (PCA), also known as Benson's syndrome. Key features include progressive higher-order visual dysfunction (Balint's syndrome: optic ataxia, simultanagnosia) and specific parietal/occipital atrophy, with relative preservation of memory and language. The question asks for the most likely underlying pathology. Medical consensus establishes that Alzheimer's Disease pathology (amyloid plaques and neurofibrillary tangles) is the underlying cause in the vast majority (>80%) of PCA cases. While the Heidenhain variant of CJD (Option B) affects vision, it typically presents with rapid progression and cortical ribboning on DWI, not just atrophy. Lewy Body Disease (Option A) can have visual features but is less likely to present as pure PCA without hallucinations or parkinsonism, and AD remains the statistical favorite. The item is medically accurate and logically sound.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed130", "question_id": "20251223T232137723Z_gemini-3-pro-preview_seed130-008", "question": "A 28-year-old male with ulcerative colitis is admitted with jaundice and pruritus. MRCP shows multifocal strictures and dilations of the intrahepatic and extrahepatic bile ducts. IgG4 levels are 2x upper limit of normal. A liver biopsy shows periductal concentric fibrosis ('onion-skinning') without abundant plasma cells. A trial of high-dose corticosteroids results in no biochemical improvement. What is the diagnosis?", "options": ["IgG4-related Sclerosing Cholangitis", "Primary Sclerosing Cholangitis (PSC)", "Cholangiocarcinoma", "Secondary Sclerosing Cholangitis", "Autoimmune Hepatitis overlap syndrome"], "answer": "B", "answer_index": 1, "explanation": "This is classic Primary Sclerosing Cholangitis (PSC) associated with IBD. While IgG4 can be elevated in PSC (up to 15% of cases), the lack of response to steroids and the classic 'onion-skin' fibrosis distinguish it from IgG4-related Sclerosing Cholangitis (IgG4-SC). IgG4-SC typically responds dramatically to steroids and shows abundant IgG4+ plasma cells on biopsy.", "generator_model": "gemini-3-pro-preview", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Gastrointestinal", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\n\\nThe vignette presents a classic case of Primary Sclerosing Cholangitis (PSC) in a young male with Ulcerative Colitis. The key diagnostic challenge presented is distinguishing PSC with elevated IgG4 from IgG4-related Sclerosing Cholangitis (IgG4-SC). The stem provides three critical discriminators that rule out IgG4-SC and confirm PSC: 1) The patient is a young male with IBD (IgG4-SC patients are typically older, >60, and less commonly have IBD); 2) The biopsy shows 'onion-skin' fibrosis without abundant plasma cells (IgG4-SC requires dense lymphoplasmacytic infiltrate with abundant IgG4+ plasma cells); 3) There is no response to corticosteroids (IgG4-SC typically shows a dramatic response, whereas PSC does not). Elevated serum IgG4 occurs in up to 15% of PSC cases and does not rule out the diagnosis. The item is medically accurate, logically sound, and uses standard board-exam discriminators to ensure a unique best answer.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\n\nThe vignette presents a classic case of Primary Sclerosing Cholangitis (PSC) in a young male with Ulcerative Colitis. The key diagnostic challenge presented is distinguishing PSC with elevated IgG4 from IgG4-related Sclerosing Cholangitis (IgG4-SC). The stem provides three critical discriminators that rule out IgG4-SC and confirm PSC: 1) The patient is a young male with IBD (IgG4-SC patients are typically older, >60, and less commonly have IBD); 2) The biopsy shows 'onion-skin' fibrosis without abundant plasma cells (IgG4-SC requires dense lymphoplasmacytic infiltrate with abundant IgG4+ plasma cells); 3) There is no response to corticosteroids (IgG4-SC typically shows a dramatic response, whereas PSC does not). Elevated serum IgG4 occurs in up to 15% of PSC cases and does not rule out the diagnosis. The item is medically accurate, logically sound, and uses standard board-exam discriminators to ensure a unique best answer.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed130", "question_id": "20251223T232137723Z_gemini-3-pro-preview_seed130-009", "question": "A 60-year-old female undergoes surveillance colonoscopy. A 15mm flat lesion is removed from the ascending colon. Pathology reveals a Sessile Serrated Lesion (SSL) with dysplasia. According to the 2020 US Multi-Society Task Force guidelines, when should her next surveillance colonoscopy be performed?", "options": ["1 year", "3 years", "5 years", "7 years", "10 years"], "answer": "B", "answer_index": 1, "explanation": "Sessile Serrated Lesions (SSLs) with dysplasia are considered high-risk precancerous lesions, equivalent in risk to high-risk adenomas (e.g., villous histology, high-grade dysplasia, or size >10mm). The recommended surveillance interval for an SSL with dysplasia (regardless of size) is 3 years. An SSL <10mm without dysplasia would be 5-10 years.", "generator_model": "gemini-3-pro-preview", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Gastrointestinal", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The item is medically accurate and logically sound. It correctly tests the 2020 US Multi-Society Task Force (USMSTF) guidelines for post-polypectomy surveillance. The vignette describes a patient with a Sessile Serrated Lesion (SSL) that is both large (>10mm) and contains dysplasia. According to the 2020 guidelines, an SSL with dysplasia is considered a high-risk lesion, and the recommended surveillance interval is 3 years (similar to high-risk adenomas). Furthermore, an SSL >10mm without dysplasia would also warrant a 3-year interval. Therefore, the presence of dysplasia and the size both independently point to the same correct answer. The stem implies complete resection (standard assumption unless 'piecemeal' is specified, which would trigger a 6-month check, not listed as an option). The keyed answer (B) is the unique best answer supported by current guidelines.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The item is medically accurate and logically sound. It correctly tests the 2020 US Multi-Society Task Force (USMSTF) guidelines for post-polypectomy surveillance. The vignette describes a patient with a Sessile Serrated Lesion (SSL) that is both large (>10mm) and contains dysplasia. According to the 2020 guidelines, an SSL with dysplasia is considered a high-risk lesion, and the recommended surveillance interval is 3 years (similar to high-risk adenomas). Furthermore, an SSL >10mm without dysplasia would also warrant a 3-year interval. Therefore, the presence of dysplasia and the size both independently point to the same correct answer. The stem implies complete resection (standard assumption unless 'piecemeal' is specified, which would trigger a 6-month check, not listed as an option). The keyed answer (B) is the unique best answer supported by current guidelines.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed130", "question_id": "20251223T232137723Z_gemini-3-pro-preview_seed130-010", "question": "A 55-year-old male with AL amyloidosis presents with extensive ecchymoses and a large hematoma after a minor venipuncture. Coagulation studies reveal a PT of 18s (Normal 11-13.5) and a PTT of 45s (Normal 25-35). Thrombin time is normal. Mixing studies correct both PT and PTT. Factor assays reveal Factor X activity of 8%. What is the mechanism of this deficiency?", "options": ["Autoantibody inhibition of Factor X", "Adsorption of Factor X onto amyloid fibrils", "Decreased hepatic synthesis of Factor X", "Urinary loss of Factor X due to nephrotic syndrome", "Consumption due to low-grade DIC"], "answer": "B", "answer_index": 1, "explanation": "Acquired Factor X deficiency is a rare but classic complication of AL amyloidosis (occurring in ~8-10% of patients). The mechanism is the adsorption (binding) of Factor X to the amyloid fibrils in the spleen and liver, removing it from circulation. It is not an inhibitor (antibody) or synthesis issue. Treatment often requires splenectomy or high-dose factor replacement to overwhelm the binding sites.", "generator_model": "gemini-3-pro-preview", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Hematology", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\n\\nThe vignette presents a classic board-exam scenario: a patient with AL amyloidosis presenting with bleeding diathesis and isolated, severe Factor X deficiency. The key stem clues are the diagnosis of AL amyloidosis, the prolonged PT/PTT that corrects with mixing (indicating deficiency, not inhibitor), and the specific finding of 8% Factor X activity. The keyed answer (B) correctly identifies the unique pathophysiology of this condition: acquired Factor X deficiency caused by adsorption of the factor onto amyloid fibrils (typically in the spleen/liver). \\n\\nThe item is logically sound. The mixing study result (correction) effectively rules out Option A (inhibitor/antibody). While liver involvement (Option C) and nephrotic syndrome (Option D) are features of amyloidosis, they do not explain isolated severe Factor X deficiency (liver failure affects Factor VII first; nephrotic syndrome typically loses Antithrombin III or Factor IX). Option E is ruled out by the lack of other DIC markers (thrombocytopenia, low fibrinogen). The question is a textbook example of a specific, high-yield medical concept.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\n\nThe vignette presents a classic board-exam scenario: a patient with AL amyloidosis presenting with bleeding diathesis and isolated, severe Factor X deficiency. The key stem clues are the diagnosis of AL amyloidosis, the prolonged PT/PTT that corrects with mixing (indicating deficiency, not inhibitor), and the specific finding of 8% Factor X activity. The keyed answer (B) correctly identifies the unique pathophysiology of this condition: acquired Factor X deficiency caused by adsorption of the factor onto amyloid fibrils (typically in the spleen/liver). \n\nThe item is logically sound. The mixing study result (correction) effectively rules out Option A (inhibitor/antibody). While liver involvement (Option C) and nephrotic syndrome (Option D) are features of amyloidosis, they do not explain isolated severe Factor X deficiency (liver failure affects Factor VII first; nephrotic syndrome typically loses Antithrombin III or Factor IX). Option E is ruled out by the lack of other DIC markers (thrombocytopenia, low fibrinogen). The question is a textbook example of a specific, high-yield medical concept.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed130", "question_id": "20251223T232137723Z_gemini-3-pro-preview_seed130-011", "question": "A 30-year-old female presents with recurrent sinopulmonary infections and splenomegaly. Labs show low IgG, low IgA, and variable IgM. She is diagnosed with Common Variable Immunodeficiency (CVID). Five years later, she develops progressive dyspnea. CT chest shows diffuse pulmonary nodules and mediastinal lymphadenopathy. Biopsy reveals non-necrotizing granulomas. Stains for fungi and mycobacteria are negative. What is the preferred initial treatment for this complication?", "options": ["Infliximab", "Rituximab and Azathioprine/Mycophenolate", "High-dose Intravenous Immunoglobulin (IVIG) alone", "Lung Transplantation", "Antituberculous therapy"], "answer": "B", "answer_index": 1, "explanation": "The patient has Granulomatous-Lymphocytic Interstitial Lung Disease (GLILD), a distinct and serious complication of CVID. Unlike sarcoidosis, GLILD in CVID is driven by B-cell hyperplasia and T-cell dysregulation. The consensus treatment for progressive GLILD is combination immunosuppression, typically Rituximab (to deplete B cells) combined with an antimetabolite like Azathioprine or Mycophenolate. IVIG alone is insufficient for GLILD.", "generator_model": "gemini-3-pro-preview", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Immunology", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The clinical vignette describes a classic presentation of Granulomatous-Lymphocytic Interstitial Lung Disease (GLILD) in a patient with Common Variable Immunodeficiency (CVID). The diagnosis is supported by the history of CVID, splenomegaly, and biopsy showing non-necrotizing granulomas with negative infectious stains. The question asks for the preferred initial treatment. While systemic corticosteroids are often used as a first-line bridge, they are not provided as an option. Among the available choices, Option B (Rituximab and Azathioprine/Mycophenolate) represents the widely accepted consensus therapy for progressive GLILD (based on the Chase et al. protocol and UK-PIN guidelines) to induce remission and spare steroids. Option A (Infliximab) is generally reserved for refractory cases or sarcoidosis, not GLILD. Option C (IVIG) is standard for CVID replacement but insufficient to treat GLILD, and high-dose IVIG has variable/poor efficacy for this specific complication compared to B-cell depletion. Option E is incorrect due to negative stains. The item is medically accurate and logically sound as the best available option.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The clinical vignette describes a classic presentation of Granulomatous-Lymphocytic Interstitial Lung Disease (GLILD) in a patient with Common Variable Immunodeficiency (CVID). The diagnosis is supported by the history of CVID, splenomegaly, and biopsy showing non-necrotizing granulomas with negative infectious stains. The question asks for the preferred initial treatment. While systemic corticosteroids are often used as a first-line bridge, they are not provided as an option. Among the available choices, Option B (Rituximab and Azathioprine/Mycophenolate) represents the widely accepted consensus therapy for progressive GLILD (based on the Chase et al. protocol and UK-PIN guidelines) to induce remission and spare steroids. Option A (Infliximab) is generally reserved for refractory cases or sarcoidosis, not GLILD. Option C (IVIG) is standard for CVID replacement but insufficient to treat GLILD, and high-dose IVIG has variable/poor efficacy for this specific complication compared to B-cell depletion. Option E is incorrect due to negative stains. The item is medically accurate and logically sound as the best available option.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed130", "question_id": "20251223T232137723Z_gemini-3-pro-preview_seed130-012", "question": "A 62-year-old male with metastatic melanoma is treated with Ipilimumab and Nivolumab. Four weeks after the second cycle, he presents with fatigue, nausea, and hypotension. Labs show Sodium 130 mEq/L, Potassium 5.2 mEq/L, Glucose 65 mg/dL. TSH is 0.05 mIU/L (Low), Free T4 is 0.6 ng/dL (Low). ACTH is <5 pg/mL. MRI brain shows enlargement of the pituitary gland. What is the diagnosis?", "options": ["Primary Adrenal Insufficiency (Addison's)", "Immune Checkpoint Inhibitor-induced Hypophysitis", "Thyroid Storm", "Pituitary Metastasis", "Syndrome of Inappropriate ADH (SIADH)"], "answer": "B", "answer_index": 1, "explanation": "This is a classic presentation of hypophysitis (inflammation of the pituitary), a specific immune-related adverse event (irAE) strongly associated with CTLA-4 inhibitors (Ipilimumab). The key biochemical pattern is central hypothyroidism (Low TSH, Low T4) and central adrenal insufficiency (Low ACTH, Low Cortisol, hyponatremia/hyperkalemia). Primary adrenal insufficiency would have high ACTH. The MRI finding confirms pituitary inflammation.", "generator_model": "gemini-3-pro-preview", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Medical Oncology", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The vignette presents a classic case of immune checkpoint inhibitor (ICI)-induced hypophysitis, specifically associated with CTLA-4 inhibitors (Ipilimumab). The clinical picture shows pan-hypopituitarism: central hypothyroidism (low TSH, low Free T4) and central adrenal insufficiency (hypotension, hypoglycemia, hyponatremia, and inappropriately low ACTH). The MRI finding of pituitary enlargement confirms the diagnosis. Option A (Primary Adrenal Insufficiency) is ruled out by the low ACTH; primary disease would cause elevated ACTH due to lack of negative feedback. Option C is ruled out by the hypothyroid labs. Option E does not explain the pituitary failure. Option D (Metastasis) is a differential diagnosis, but the specific drug history and classic hormonal profile make hypophysitis the intended best answer. A minor medical inaccuracy exists: the patient has hyperkalemia (K 5.2), which is typical of primary mineralocorticoid deficiency (Addison's) but rare in central adrenal insufficiency where the RAAS system preserves aldosterone secretion. However, the ACTH level and concurrent thyroid failure definitively point to the pituitary, making B the only logically defensible answer despite the electrolyte nuance.\",\"medical_accuracy_score\":\"4\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The vignette presents a classic case of immune checkpoint inhibitor (ICI)-induced hypophysitis, specifically associated with CTLA-4 inhibitors (Ipilimumab). The clinical picture shows pan-hypopituitarism: central hypothyroidism (low TSH, low Free T4) and central adrenal insufficiency (hypotension, hypoglycemia, hyponatremia, and inappropriately low ACTH). The MRI finding of pituitary enlargement confirms the diagnosis. Option A (Primary Adrenal Insufficiency) is ruled out by the low ACTH; primary disease would cause elevated ACTH due to lack of negative feedback. Option C is ruled out by the hypothyroid labs. Option E does not explain the pituitary failure. Option D (Metastasis) is a differential diagnosis, but the specific drug history and classic hormonal profile make hypophysitis the intended best answer. A minor medical inaccuracy exists: the patient has hyperkalemia (K 5.2), which is typical of primary mineralocorticoid deficiency (Addison's) but rare in central adrenal insufficiency where the RAAS system preserves aldosterone secretion. However, the ACTH level and concurrent thyroid failure definitively point to the pituitary, making B the only logically defensible answer despite the electrolyte nuance.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed130", "question_id": "20251223T232137723Z_gemini-3-pro-preview_seed130-013", "question": "A 22-year-old female presents with recurrent episodes of abdominal pain and extremity swelling lasting 2-3 days. She has no urticaria during these episodes. Her C4 level is consistently low. C1-Inhibitor (C1-INH) quantitative level is 8 mg/dL (Normal 19-37) and C1-INH functional activity is 15% (Normal >68%). Which of the following is the most appropriate long-term prophylactic therapy?", "options": ["Antihistamines (Cetirizine)", "Omalizumab", "Danazol or Lanadelumab", "Systemic Corticosteroids", "Epinephrine auto-injector"], "answer": "C", "answer_index": 2, "explanation": "The patient has Hereditary Angioedema (HAE) Type 1 (low C1-INH level and function). HAE is bradykinin-mediated, not histamine-mediated; therefore, antihistamines, corticosteroids, and epinephrine are ineffective. Long-term prophylaxis is indicated for frequent attacks. Options include attenuated androgens (Danazol) or modern agents like Lanadelumab (kallikrein inhibitor) or Berotralstat. C1-INH replacement is also used.", "generator_model": "gemini-3-pro-preview", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Allergy/Immunology", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V (Valid). The vignette presents a classic case of Hereditary Angioedema (HAE) Type I, confirmed by recurrent angioedema without urticaria, low C4, low quantitative C1-INH, and low functional C1-INH. The question asks for long-term prophylactic therapy. HAE is bradykinin-mediated, making mast-cell/histamine-targeted therapies (antihistamines, epinephrine, corticosteroids, omalizumab) ineffective. Option C correctly identifies Danazol (attenuated androgen) and Lanadelumab (monoclonal antibody against plasma kallikrein) as agents used for long-term prophylaxis. While modern guidelines generally favor Lanadelumab over androgens due to side effects, both are indicated for this purpose, and Option C is the only choice containing effective medications for HAE. The distractors are clearly incorrect as they treat histamine-mediated angioedema or urticaria. The item is medically accurate and logically sound.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V (Valid). The vignette presents a classic case of Hereditary Angioedema (HAE) Type I, confirmed by recurrent angioedema without urticaria, low C4, low quantitative C1-INH, and low functional C1-INH. The question asks for long-term prophylactic therapy. HAE is bradykinin-mediated, making mast-cell/histamine-targeted therapies (antihistamines, epinephrine, corticosteroids, omalizumab) ineffective. Option C correctly identifies Danazol (attenuated androgen) and Lanadelumab (monoclonal antibody against plasma kallikrein) as agents used for long-term prophylaxis. While modern guidelines generally favor Lanadelumab over androgens due to side effects, both are indicated for this purpose, and Option C is the only choice containing effective medications for HAE. The distractors are clearly incorrect as they treat histamine-mediated angioedema or urticaria. The item is medically accurate and logically sound.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed130", "question_id": "20251223T232137723Z_gemini-3-pro-preview_seed130-014", "question": "A 72-year-old male is evaluated for frequent falls. He reports that his legs feel 'heavy' and 'stuck to the floor' when he tries to start walking, but once moving, he can walk relatively well. He has urinary urgency and mild cognitive impairment. Physical exam reveals a broad-based, shuffling gait with difficulty lifting feet (magnetic gait). What is the most likely diagnosis?", "options": ["Parkinson's Disease", "Normal Pressure Hydrocephalus (NPH)", "Lumbar Spinal Stenosis", "Vascular Dementia", "Cerebellar Ataxia"], "answer": "B", "answer_index": 1, "explanation": "The clinical triad of gait disturbance, urinary incontinence (urgency), and dementia ('wobbly, wet, and wacky') suggests Normal Pressure Hydrocephalus (NPH). The specific description of a 'magnetic gait' (gait apraxia where feet appear stuck to the floor) is the hallmark and usually the earliest sign. It is distinguished from Parkinson's by the lack of resting tremor and the specific nature of the gait initiation failure.", "generator_model": "gemini-3-pro-preview", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Geriatrics", "judge_model": "gemini-3-pro-preview", "judge_model_outputs_raw": "{\"analysis\":\"The vignette describes the classic clinical triad of Normal Pressure Hydrocephalus (NPH): gait disturbance, urinary urgency, and cognitive impairment (often mnemonically 'wobbly, wet, and wacky'). The specific description of the gait as 'magnetic' (feet feeling stuck to the floor), broad-based, and shuffling is the hallmark of NPH (frontal gait apraxia). This specific gait pattern discriminates the condition from Parkinson's disease (Option A), which typically presents with a narrow-based, festinating gait, and Cerebellar Ataxia (Option E), which presents with a wide-based, lurching, uncoordinated gait without the 'magnetic' quality. Lumbar spinal stenosis (Option C) typically presents with neurogenic claudication (pain/paresthesia relieved by flexion), not gait apraxia. While Vascular Dementia (Option D) can present with similar gait findings (vascular parkinsonism), the explicit use of 'magnetic gait' alongside the full triad points definitively to NPH as the intended best answer in a board-exam context. The item is logically sound and medically accurate.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "The vignette describes the classic clinical triad of Normal Pressure Hydrocephalus (NPH): gait disturbance, urinary urgency, and cognitive impairment (often mnemonically 'wobbly, wet, and wacky'). The specific description of the gait as 'magnetic' (feet feeling stuck to the floor), broad-based, and shuffling is the hallmark of NPH (frontal gait apraxia). This specific gait pattern discriminates the condition from Parkinson's disease (Option A), which typically presents with a narrow-based, festinating gait, and Cerebellar Ataxia (Option E), which presents with a wide-based, lurching, uncoordinated gait without the 'magnetic' quality. Lumbar spinal stenosis (Option C) typically presents with neurogenic claudication (pain/paresthesia relieved by flexion), not gait apraxia. While Vascular Dementia (Option D) can present with similar gait findings (vascular parkinsonism), the explicit use of 'magnetic gait' alongside the full triad points definitively to NPH as the intended best answer in a board-exam context. The item is logically sound and medically accurate.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}]